Genitourinary Cancer News & Features

Inherited high-risk mutation for prostate cancer identified

January 26, 2012

Researchers have discovered a rare but recurrent mutation that increases the risk of hereditary prostate cancer by up to 20 times.
 

Music-playing headphones keep men calm during prostate biopsy

January 25, 2012

Providing men with noise-canceling headphones that play music may be a simple intervention for reducing their anxiety and pain perception while they are undergoing a prostate biopsy.
 

Experts have conflicting views on CV risk in prostate cancer therapy

Delicia Honen Yard December 20, 2011

A meta-analysis provides reassurance that androgen deprivation therapy is not associated with an increased risk of cardiovascular deaths, but other specialists warn against ignoring this risk.
 

Denosumab shown to delay bone metastases in prostate cancer

Delicia Honen Yard November 30, 2011

A monoclonal antibody that disrupts the activation of osteoclasts increased bone-metastasis-free (BMF) survival in men with prostate cancer in a recent large trial.
 

Costly clots common in cancer

Delicia Honen Yard October 18, 2011

As many as 1 in 5 people risk developing a venous thromboembolism (VTE) within a year after undergoing treatment for some types of cancers, researchers reported.
 

High-intensity ultrasound for prostate cancer showed strong 10-year results

Delicia Honen Yard May 31, 2011

A large analysis has demonstrated good long-term outcomes for men who had undergone high-intensity focused ultrasound (HIFU) as a treatment for prostate cancer.
 

Overall cancer mortality rates decrease, but incidence of some cancers increases

Delicia Honen Yard April 08, 2011

Overall, cancer incidence rates fell approximately 1% annually and overall death rates decreased by an average of 1.6% annually between 2003 and 2007.
 

Low increased risk of second cancer after radiotherapy

Delicia Honen Yard April 05, 2011

Only a relatively small proportion of second cancers in adults is related to routine radiotherapy administered for initial disease, according to the findings of a recent study.
 

Genitourinary Cancer Clinical Trials

Clinical Trial: Atkins Diet and Prostate Cancer Clinical Trial

Clinical Trial: Patient Empowerment and Risk-assessed Treatment to Improve Outcome in the Elderly After Onco-surgery.

Clinical Trial: Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer

Clinical Trial: Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers

Clinical Trial: Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT)

Free CE from mycme.com

Discussions on Emerging Concepts and Controversies in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer

2.00 / AMA PRA Category 1 Credit(s)TM
This program reviews developments in maintenance therapy and evaluates the relevance of tumor histology and biomarker analysis for the management of NSCLC patients.
 

Let us know what you are looking for in a new oncology nursing journal:

Click here to take our survey

Cancer care is expensive.
CancerCare can help.


Connect Booklets
 Subscribe to the RSS for this page  [view all our RSS feeds here]

Web Exclusives

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

In HER2 breast cancer, lapatinib works better with trastuzumab than without

February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions